Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center. Mediterr J Hematol Infect Dis [Internet]. 2026 Apr. 30 [cited 2026 Jun. 30];18(1). Available from: https://www.mjhid.org/mjhid/article/view/6334